| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 932.79B | 963.21B | 922.52B | 950.66B | 906.02B | 821.57B |
| Gross Profit | 124.52B | 140.51B | 123.66B | 119.61B | 87.36B | 109.83B |
| EBITDA | 91.72B | 106.35B | 89.17B | 89.25B | 60.33B | 85.01B |
| Net Income | 27.64B | 54.98B | 22.39B | 23.08B | 10.36B | 44.42B |
Balance Sheet | ||||||
| Total Assets | 1.18T | 1.24T | 1.20T | 1.18T | 1.17T | 1.08T |
| Cash, Cash Equivalents and Short-Term Investments | 104.46B | 123.16B | 119.84B | 90.02B | 99.70B | 126.45B |
| Total Debt | 216.64B | 203.49B | 231.26B | 194.04B | 184.15B | 111.48B |
| Total Liabilities | 499.94B | 513.09B | 506.79B | 483.10B | 493.88B | 417.99B |
| Stockholders Equity | 649.75B | 697.70B | 666.97B | 665.71B | 643.05B | 637.35B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 42.31B | 60.44B | 12.24B | -82.08B | 28.14B |
| Operating Cash Flow | 0.00 | 89.03B | 94.06B | 64.58B | -18.86B | 75.42B |
| Investing Cash Flow | 0.00 | -20.58B | -51.11B | -52.44B | -57.04B | -27.17B |
| Financing Cash Flow | 0.00 | -66.13B | -18.77B | -27.81B | 41.53B | -42.19B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥540.72B | 9.78 | 6.90% | 2.71% | 4.41% | 176.65% | |
76 Outperform | ¥142.79B | 6.66 | 10.46% | 2.35% | 2.55% | 72.25% | |
74 Outperform | ¥76.79B | 21.16 | ― | 6.64% | 2.45% | 1.87% | |
69 Neutral | ¥61.68B | 15.41 | ― | 3.31% | 2.25% | 30.32% | |
65 Neutral | ¥25.86B | 8.78 | ― | 6.14% | -1.56% | 17.80% | |
63 Neutral | ¥96.26B | 12.05 | 7.53% | 3.01% | 5.17% | 20.88% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |